Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Legal Officer

Chief Financial Officer

Chief Executive Officer

General Counsel

Chief Commercial Officer

Chief Medical Officer

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment of fungal infections in the United States. It offers BREXAFEMME for the treatment of vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, an intravenous drug for the treatment of various fungal infections, including invasive candidiasis, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment of fungal infections in the United States.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-16	Premium	sold (taxes)	Premium	Premium	Premium	Chief Legal Officer
2024-01-26	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-26	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-01-26	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-05-15	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-01-27	Premium	acquired	Premium	Premium	Premium	General Counsel
2023-01-01	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-10-24	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-06-17	Premium	acquired	Premium	Premium	Premium	-
2022-06-17	Premium	acquired	Premium	Premium	Premium	-
2022-06-17	Premium	acquired	Premium	Premium	Premium	-
2022-06-17	Premium	acquired	Premium	Premium	Premium	-
2022-06-17	Premium	acquired	Premium	Premium	Premium	-
2022-06-17	Premium	acquired	Premium	Premium	Premium	-
2022-04-26	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-04-26	Premium	bought	Premium	Premium	Premium	General Counsel
2022-02-04	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-02-04	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2022-02-04	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer

SCYX - SCYNEXIS Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for SCYX